Patient-specific stem cells and cardiovascular drug discovery
JAMA
.
2013 Nov 20;310(19):2039-40.
doi: 10.1001/jama.2013.282409.
Authors
Nicholas M Mordwinkin
1
,
Andrew S Lee
,
Joseph C Wu
Affiliation
1
Stanford Cardiovascular Institute2Department of Medicine, Division of Cardiology3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California.
PMID:
24240927
PMCID:
PMC4033311
DOI:
10.1001/jama.2013.282409
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Cardiovascular Agents / pharmacology*
Drug Discovery*
Humans
Myocytes, Cardiac*
Pluripotent Stem Cells*
Precision Medicine
Substances
Cardiovascular Agents
Grants and funding
R01 HL113006/HL/NHLBI NIH HHS/United States
T32 EB009035/EB/NIBIB NIH HHS/United States
U01 HL107393/HL/NHLBI NIH HHS/United States
HHMI/Howard Hughes Medical Institute/United States